Ann: Intiger Commences Pilot and Partnership Program, page-650

Hey @onix786, for your viewing pleasure ...



Just a few caveats:
- this is my interpretation only, based on MF's confidence that M1-M4 NPAT targets will be hit by 30/6/19 with Sentry deal alone
- performance shares can be only measured against profit targets and issued as at 30th June each year between now and 30/6/19
- Based on MF's confidence, I've taken a guess at what the NPAT will be each year and then applied what I believe is a reasonable PE multiple based on the year on year NPAT growth figure
- remember that markets are forward looking, so they start to price in future profits once they gain some expectation/confidence that the profit figures will be achieved
- I'm more concerned with the likely overall trend in NPAT growth and the S/P following this explosive growth trend upwards over time rather than the actual numbers themselves
- this is really just a guestimate at this stage until we know things like numbers of practices (thinking Sentry might be about ~130), average revenue per practice (maybe $100K pa), profit margin (maybe 40% once fully functioning), KLIP revenue (extra 10% of gross revenues
- MOU 2 will likely blow these figures out of the water if it is actually a NAB, AMP, IOOF

Keep smiling